FOLH1 and prostate carcinoma: To evaluate cell-type-specific delivery of mRNA-LNPs pre-mixed with BsAbs, we used MDA-MB-468 breast cancer cells, which express EGFR but not PSMA, and LNCaP prostate cancer cells, which express both EGFR and PSMA (Figure S1C).